# Globopharma, Inc. – FDA Inspection, Aug 10, 2026

Source: https://www.keypedia.com/records/fda_inspections/globopharma-inc/f7a8a4eb-94ae-48ec-9fa5-55fa78530d43
Source feed: FDA_Inspections

> FDA inspection 1330352 of Globopharma, Inc., August 10, 2026. Classification: Voluntary Action Indicated (VAI). 2 citations under 21 CFR part 111. Form 483 issued. 3 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1330352
- Company Name: Globopharma, Inc.
- Inspection Date: 2026-08-10
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Food Composition, Standards, Labeling and Econ
- Product Type: Foods & Cosmetics
- Center: Foods & Cosmetics
- Office Name: Florida District Office
- Citation Count: 2

## Related Documents

- [FDA Inspection 1241516 - 2024-06-21](https://www.keypedia.com/records/fda_inspections/globopharma-inc/4c7249d1-abb6-4c50-aeb4-374cebbb149a)
- [FDA Inspection 1211491 - 2023-07-28](https://www.keypedia.com/records/fda_inspections/globopharma-inc/c2562910-7953-47c3-bbd1-682ff21c7348)
- FDA Inspection 1095015 - 2019-07-02

## Related Officers

- [Investigator](https://www.keypedia.com/people/megan-k-otero/bac65e8e-6e3f-4547-8627-5fb299853eb6)

Company: https://www.keypedia.com/companies/globopharma-inc/4fc71235-d5ac-4564-8fe1-2b57e567d3c0

Office: https://www.keypedia.com/offices/florida-district-office/95b2a118-0b78-46e0-a54c-982bd7ce51c9